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perfusion was evaluated by myocardial perfusion grade (MBG). All the
patients were divided into good perfusion group (MBG 2, n¼137) and
poor perfusion group (MBG 1, n¼31) according to post intervention
MBG. The MPV, white blood cell (WBC) count, and so on were
compared. And the correlative factors were analyzed to ﬁnd out the
predictors of myocardial perfusion post PPCI.
RESULTS The MPV (11.21.4 fL vs. 9.51.3 fL, P <0.001) and WBC
count (11.11.0 109/L vs. 10.11.3 109/L, P <0.001) were higher in
poor perfusion group comparing with the good perfusion group.
Multivariate logistic regression analysis showed that MPV (OR 0.42,
95% CI 0.28-0.61, P <0.001) and WBC count (OR 0.59, 95% CI 0.39-
0.90, P ¼0.015) were the predictors of poor myocardial perfusion after
PPCI. MPV was also correlated with post PPCI MBG (r ¼ -0.607,
P<0.001) and LVEF (r ¼ -0.621, P <0.001).
CONCLUSIONS In STEMI patient receiving PPCI, higher pre-inter-
vention MPV and WBC count means poor myocardial perfusion, and
higher MPV also indicates worse left ventricular systolic function post
PPCI.
GW26-e4776
A new cooperative approach in treatment of acute myocardial
infarction in China
Jinchuan Yan
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OBJECTIVES Acute myocardial infarction (AMI) is the most serious
type of coronary heart disease that affect the life and health of people,
but < 30% of all of the patients with AMI have been treated effectively
and timely in China. Delayed treatment has been considered as a
leading cause of death and severe outcomes. This study aimed to
evaluate a new regional cooperative emergency model in improving
the ﬁrst medical contact-to-balloon time and the therapeutic effects
on patients with ST-elevation myocardial infarction (STEMI).
METHODS A new regional cooperative emergency model was estab-
lished in some regions of Zhenjiang, Jiangsu province in China. A
retrospective analysis of 458 STEMI patients before and after the
model used in these regions was performed. Patients were divided
into two groups in terms of before or after the regional cooperative
rescue model used: model group (n¼285) and control group (n¼173).
The ﬁrst medical contact-to-balloon (FMC-to-B) time, door-to-balloon
(D-to-B) time, referral time, cardiac function, mean cost, days of
hospitalization, and major adverse cardiac events (MACE) were
analyzed.
RESULTS The mean FMC-to-B time, D-to-B time and referral time of
the model group were 97  20, 22  8, 61  17 min, respectively, these
parameters were signiﬁcantly lower than the corresponding indexes
of the control group (211  27, 105  14, 101  19 min). Six months after
the patients were discharged from the hospital, the left ventricular
ejection fraction (LVEF) of the model group increased but left ven-
tricular end-diastolic dimension (LVED) was decreased when
compared with control group. These results also showed that mean
costs (43813.0  2731.0 vs 50471.0  5264.0 CNY) and days of hospi-
talization (7.85  3.15 vs 11.02  4.06 days) were reduced. The inci-
dence rate of MACE in the model group was 8.2%, which was lower
than the rate of 16.8% in the control group.
CONCLUSIONS Regional cooperative emergency model may decrease
the FMC-to-B time, which could improve the cardiac function, ther-
apeutic effect on patients with AMI, and decrease ﬁnancial burden of
patients.
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OBJECTIVES Due to the severity of acute myocardial infarction (AMI)
and cardiovascular interventions, many patients should be prescribed
multiple anti-platelet therapy to reduce platelet aggregation. We
aimed to explore the inﬂuence of the loading-dose of multiple
anti-platelet drugs on the inhibition of platelet aggregation in patients
with AMI.
METHODS The present study included 84 patients who were initially
diagnosed with AMI. Patients were divided into 3 groups randomly:AC group (aspirin 0.3g plus clopidogrel 0.3g), ATG group (aspirins 0.3g
plus ticagrelor 0.18g), and ACTF group (triple therapy with aspirins
0.3g, clopidogrel 0.3g and tiroﬁban 0.15ug/kg/min). Adenosine
diphosphate(ADP)-induced platelet aggregation was measured using
the multiplate analyzer at the time of initial diagnose of AMI, 2 hours
after taking loading-dose of anti-platelet therapy, and the second
morning.
RESULTS There were no signiﬁcant differences in demographic
characteristics among groups, including age, risk factors and sex. In
the ADP-induced platelet aggregation ratio, there were not statisti-
cally signiﬁcant among groups at the time of initial diagnose of AMI.
However, there was signiﬁcant difference between before and after
the administration of anti-platelet drugs (53.3%11.2% vs 27.9%
8.5%, p<0.05) in all patients. The platelet aggregation ratio of triple
therapy groups was signiﬁcantly lower than dual anti-platelet ther-
apy, both at the time of 2h after administration drugs and the second
morning(14.3%6.3% vs 23.5%9.4%, p<0.05; 16.4%8.5% vs 33.5%
9.4%). Compared with AC group, ATG group had a signiﬁcantly lower
platelet aggregation ratio at the time of 2 hours after administer drugs
(26.4%7.8% vs 20.6%4.5%, p<0.05). There were no signiﬁcant
differences between AC group and ATG group at the second morning
(32.5%6.4% vs 34.5%7.3%, p¼0.3).
CONCLUSIONS Addition tiroﬁban to conventional dual anti-platelet
therapy can reduce drastically platelet aggregation ratio for the pa-
tients with AMI. Compared to aspirin combination with clopidogrel,
aspirin plus ticagrelor had better inhibiting effect in 2 hours after
administration.
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healthy people by genome-wide gene expression proﬁling in
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OBJECTIVES The polygenic inheritance and the dependence on
environmental factors pose a challenge for the diagnosis and treat-
ment of coronary heart disease (CHD). We hypothesized that a mo-
lecular diagnostic assay using easily accessible peripheral blood
would greatly assist in the screening and diagnosis of CHD. In order to
validate this a microarray analysis was carried out, the results indi-
cated that there were some genes had differential expression. We
discussed the function of these differential genes in the process of the
occurrence and development of CHD and further evaluated their
diagnostic potential in CHD.
METHODS A total of 26 subjects (n¼26) were recruited in this study
including 13 CHD and 13 healthy people. The total mRNA of the sub-
jects were isolated from leukocyte in the peripheral blood within 4
hours after collection, and were reversed-transcribed to cDNAs as
soon as possible. We constructed 2 pools of 3 subjects (3 CHD and 3
healthy people) for microarray screening with Affymetrix GeneChip
Scanner 3000 to discover new biomarkers and candidate genes. The
results were analyzed with SAM, GO, KEGG. The other samples were
used for RT-PCR to conﬁrm the microarray on the next step.
Randomly selected three candidate genes from the results of micro-
array for RT-PCR: CYP4F3 acted as up-regulated group, IL13RA1 acted
as normal expression group, MED6 acted as down-regulated group.
The results of RT-PCR was analyzed by 2-DDCt method.
RESULTS The results of microarray were analyzed by Affymetrix
Expression Console Software. With the choice criterion of p0.05,
logFC1 or logFC-1, there were 300 differential genes being selected,
among them 30 genes had over expression and 270 genes had low
expression. Analyzed by GO showed these 300 genes belonged to 105
cellular components, and involved in 295 biological processes and
participated in the regulation of 212 molecular functions. Analyzed by
KEGG showed that these genes took part in 75 gene pathways. The results
of RT-PCR analyzed with 2-DDCt method showed that compared to healthy
people, the expression of CYP4F3 gene was 2.06  0.57 (p¼0.004), the
expression of IL13RA1 gene was 0.96 0.05 (p¼0.870), and the expression
of MED6 gene was 0.62  0.12 (p¼0.002). All the results obtained from
RT-PCR were in accordance with the results of microarray.
CONCLUSIONS The microarray can be used as the foundation of
exploring the pathogenic gene for coronary heart disease, and the
differential expression of CYP4F3 or MED6 may take effect on the
process of the occurrence and development of coronary heart disease.
It can be conjectured that these ﬁndings may serve to identify new
